kral oyun
Helicos BioSciences Corporation
contact us
Home|Products|Technology|Sequencing Services|Applications|Customer Support|HeliSphere Center|Corporate
Investors
Overview                                                                                                  
Press Releases                                                                                                  
Events & Presentations                                                                                                  
Corporate Governance                                                                                                  
Management and Senior Advisors                                                                                                  
Board of Directors                                                                                                  
Committee Composition                                                                                                  
Committee Charters                                                                                                  
Business Conduct & Ethics                                                                                                  
Financial Information                                                                                                  
SEC Filings                                                                                                  
Section 16 Filings                                                                                                  
Annual Reports                                                                                                  
Quarterly Reports                                                                                                  
Stock Information                                                                                                  
Home Investor Relations SEC Filings

SEC Filings
print page  |  email page
  
Filing Description Date Filed Sorted Descending Size  
10-Q quarterly report May 14, 2012 328.1 KB  
10-K/A amended annual report Apr 17, 2012 54.8 KB  
8-K current report Apr 10, 2012 81.1 KB  
10-K annual report Mar 30, 2012 1.3 MB  
8-K current report Mar 9, 2012 24.8 KB  
5 trifunovich ivan Feb 13, 2012 25.2 KB  
SC 13G/A amended statement of beneficial ownership Feb 10, 2012 187.8 KB  
8-K current report Jan 10, 2012 23.9 KB  
CT ORDER confidential treatment order Jan 4, 2012 6.2 KB  
CT ORDER confidential treatment order Dec 20, 2011 9.5 KB  
8-K current report Dec 1, 2011 54.2 KB  
10-Q/A amended quarterly report Nov 16, 2011 377.1 KB  
10-Q quarterly report Nov 14, 2011 372.4 KB  
4 trifunovich, ivan Nov 9, 2011 25.0 KB  
8-K current report Sep 22, 2011 300.8 KB  
8-K current report Sep 13, 2011 23.0 KB  
8-K current report Aug 30, 2011 41.8 KB  
10-Q quarterly report Aug 12, 2011 300.1 KB  
4 moore, jeffrey r. Jul 6, 2011 24.2 KB  
8-K current report Jun 30, 2011 23.7 KB  
Showing 1-20 of 308 Page: 1 2 3 ... 16  Next 20
617-264-1950
investorrelations@helicosbio.com

HLCS (OT)   May 17, 2012

$0.07         0.00           -

Quotes delayed at least 20 minutes. Information provided by eSignal.

Email alerts sign-up
Fine-tune the emails you receive from Helicos Biosciences Corporation with specific SEC filing types, news types, and stock price changes. Choose to receive the closing stock price each day, or a summary of stock prices at the end of the week.

Sign-up now


RSS news feed sign-up.
Subscribe to RSS news feeds to automatically be notified of SEC filings and news releases.

Sign-up now


Search Investor Relations.
  Investor site
  Section only


© 2012 Helicos Biosciences Corporation  •  One Kendall Square, Building 700 Cambridge, MA 02139  •  877-2-HELICOS      contact us   |   terms of use   |   privacy policy